CD24 Expression as a Marker for Predicting Clinical Outcome in Human Gliomas

Table 2

Statistics of CD24 mRNA levels in glioma.

	No. of cases	CD24 mean (SD)	P
Tissue type
Control	10	0.065 (0.087)	<0.001
Glioma	151	2.386 (0.230)
WHO grade
I	31	0.873 (0.101)	<0.001
II	37	1.552 (0.113)
III	40	3.021 (0.220)
IV	43	3.604 (0.378)
KPS
≥80	66	1.328 (0.162)	<0.001
<80	85	3.208 (0.331)